NK-cell lymphoma with nodal presentation and expression of cutaneous lymphocyte-associated antigen

Pathology Research and Practice

Volumn 206, Issue 7, 2010, Pages 463-466

  Chang, Sheng Tsung ^a   Liao, Yung Liang ^a   Lin, Shu Hui ^a   Chuang, Shih Sung ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cutaneous lymphocyte associated antigen; EBV; NK cell lymphoma; NK T cell lymphoma; Taiwan

Indexed keywords

ANTINEOPLASTIC AGENT; BETA F1 ANTIGEN; CD16 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CELL ANTIGEN; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYCLOPHOSPHAMIDE; EPIRUBICIN; GRANZYME B; LACTATE DEHYDROGENASE; LYMPHOCYTE ANTIGEN; PREDNISOLONE; T CELL INTRACELLULAR ANTIGEN 1; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG; VINCRISTINE; CTAGE1 PROTEIN, HUMAN; MEMBRANE PROTEIN; T LYMPHOCYTE ANTIGEN; TUMOR MARKER;

ADULT; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; CANCER INFILTRATION; CASE REPORT; CELL LINEAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DROWSINESS; EPSTEIN BARR VIRUS; FEVER; GENE REARRANGEMENT; HEPATOMEGALY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INGUINAL LYMPH NODE; INTESTINE LYMPHOMA; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHADENOPATHY; MALE; MITOSIS RATE; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHYSICAL EXAMINATION; PROGNOSIS; SKIN LYMPHOMA; SPLENOMEGALY; T LYMPHOCYTE RECEPTOR GENE; THROMBOCYTOPENIA; TUMOR CELL; TUMOR VOLUME; BIOSYNTHESIS; COMPLICATION; EPSTEIN BARR VIRUS INFECTION; FATALITY; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY; T CELL LYMPHOMA;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOMA, T-CELL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954031599     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.07.001     Document Type: Article

References (16)

1. Chan J.K.C., Jaffe E.S., Ralfkiaer E. Extranodal NK/T-cell lymphoma, nasal type. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue 2001, 204-207. IARC Press, Lyon. H.N. Jaffe ES, H. Stein, J.W. Vardiman (Eds.).
2. Emile J.F., Boulland M.L., Haioun C., et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996, 87:1466-1473.
3. Chan J.K., Sin V.C., Wong K.F., et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997, 89:4501-4513.
4. Alon R., Rossiter H., Wang X., Springer T.A., Kupper T.S. Distinct cell surface ligands mediate T lymphocyte attachment and rolling on P and E selectin under physiological flow. J. Cell Biol. 1994, 127:1485-1495.
5. Tsuchiyama J., Yoshino T., Toba K., et al. Induction and characterization of cutaneous lymphocyte antigen on natural killer cells. Br. J. Haematol. 2002, 118:654-662.
6. Yoshino T., Nakamura S., Suzumiya J., et al. Expression of cutaneous lymphocyte antigen is associated with a poor outcome of nasal-type natural killer-cell lymphoma. Br. J. Haematol. 2002, 118:482-487.
7. Chim C.S., Ma E.S., Loong F., Kwong Y.L. Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement. J. Clin. Pathol. 2005, 58:443-445.
8. Takahashi E., Asano N., Li C., et al. Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology 2008, 52:585-596.
9. Chuang S.S., Lin C.N., Shen F.C., et al. Detecting clonal rearrangement in non-Hodgkin's lymphomas in Taiwan by polymerase chain reaction. Leuk. Lymphoma 2003, 44:117-121.
10. Kwong Y.L. Natural killer-cell malignancies: diagnosis and treatment. Leukemia 2005, 19:2186-2194.
11. Wong K.F., Chan J.K., Ng C.S., Lee K.C., Tsang W.Y., Cheung M.M. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum. Pathol. 1992, 23:798-804.
12. Kern W.F., Spier C.M., Hanneman E.H., Miller T.P., Matzner M., Grogan T.M. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992, 79:2432-2437.
13. Tsang W.Y., Chan J.K., Yip T.T., et al. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Hum. Pathol. 1994, 25:758-765.
14. Lu D., Lin C.N., Chuang S.S., Hwang W.S., Huang W.T. T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute. Leuk. Lymphoma 2004, 45:923-928.
15. S.S. Chuang, S.T. Chang, W.Y. Chuang, et al., NK-cell lineage predicts poor survival in primary intestinal NK- and T-cell lymphomas, Am. J. Surg. Pathol. (in press), doi:10.1097/pas.0b013e3181a95c63.
16. Magro C.M., Dyrsen M.E. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates. J. Cutaneous Pathol. 2008, 35:1040-1049.